Frovatriptan Succinate Tablet, Film Coated
Product Images NDC 68462-694

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Frovatriptan Succinate (NDC 68462-694). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ctn2.5mg9s.jpg (Ctn2.5mg9s.jpg)

Packaging label for Frovatriptan Succinate Tablets 2.5 mg from Glenmark Pharmaceuticals Inc., USA. The label shows a unit-dose blister card containing 9 film-coated oral tablets. It includes storage instructions and manufacturer information with NDC 68462-694-97 visible.*

FDA Label Image

Figure-1 (Figure 1)

A line graph depicting the estimated probability of response over time (hours) from the initial dose for Frovatriptan Succinate Tablets 2.5 mg compared to placebo. The solid line represents Frovatriptan Succinate, which shows a higher probability of response increasing up to 2 hours, while the dashed line shows the placebo with a lower response rate.*

FDA Label Image

Figure-2 (Figure 2)

A line graph comparing the estimated probability of remediation or rescue over 24 hours after the initial dose of Frovatriptan Succinate Tablets 2.5 mg versus placebo. The horizontal axis shows time from initial dose in hours, and the vertical axis shows the estimated probability percentage. The graph includes a solid line for Frovatriptan Succinate Tablets and a dashed line for placebo, with the placebo line showing a higher probability increase over time.*

FDA Label Image

Glenmark-logo (Glenmark Logo)

FDA Label Image

Logo.jpg (Logo)

FDA Label Image

Structure (Structure)

Chemical structure of frovatriptan succinate showing the molecular arrangement of its atoms, including the indole ring, amide group, and succinate moiety with water of hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.